Metastatic Pancreatic AdenocarcinomaPhase 1/2NCT03608631Papers
Mesenchymal Stromal Cells-derived Exosomes with KRAS G12D siRNA
IExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer
What the film says
This trial is for adults with pancreatic cancer that carries a KRAS mutation.
The idea: ELI-002 7P is a vaccine given as a shot under the skin, aimed at mutated KRAS. It is combined with mFOLFIRINOX chemotherapy given before surgery. Some patients also get tislelizumab, an immunotherapy antibody given by vein.
The study looks at safety, and whether the treatment works against the cancer.
This phase 1 study plans 20 patients. At Memorial Sloan Kettering Cancer Center in New York, Kevin Soares leads it.
Public record; not medical advice.
Sources behind this film
Adults; KRAS-mutant pancreatic cancer; ELI-002 7P under the skin; with mFOLFIRINOX before surgery; ± tislelizumab IV; Safety and effectiveness; Phase 1; 20; MSK; Kevin Soares
The drug
a subcutaneous (SC) injection under the skin
neoadjuvant mFOLFIRINOX (5-Fluorouracil,oxaliplatin, leucovorin, irinotecan)
This is an open-label, multi-institution pilot study of neoadjuvant mFOLFIRINOX (5-Fluorouracil, oxaliplatin, leucovorin, irinotecan) and a lipid-conjugated Kristin-Ras (KRAS) therapeutic cancer immunotherapy (ELI-002 7P vaccine), with or without Tislelizumab, in patients diagnosed with resectable or borderline resectable pancreatic ductal adenocarcinoma (PDAC).
The study
The researchers are doing this study to find out whether ELI-002 7P in combination with mFOLFIRINOX, with or without tislelizumab, is a safe treatment approach in people who have pancreatic ductal adenocarcinoma (PDAC) with a KRAS mutation. In addition, the researchers are doing this study to find out whether the study treatment is effective against PDAC.
Eligibility
Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.
For you, or someone you love
A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.
Then $9 a month. Cancel anytime.
Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.
Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.
Ask about your own file, and walk in with questions for your oncologist or the trial team.
Share one profile with the family helping you, and with your doctors.
Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.